CellCrine is a startup based in the United States, 1 tracked investor.
Based in the United States, CellCrine is a startup. Brouky records 1 investor associated with the company.
CellCrine develops a patented chemically defined basal media supplement (BAP-CDS) that improves cell culture performance across multiple cell types and aims to replace fetal bovine serum in bioprocessing, cell therapy, and cultivated meat production.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.